Back to Journals » Hepatic Medicine: Evidence and Research » Volume 9

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

Total article views   HTML views PDF downloads Totals
9,164 Dovepress* 7,922+ 1,172 9,094
PubMed Central* 1,242 192 1,434
Totals 9,164 1,364 10,528
*Since 25 September 2017

View citations on PubMed Central and Google Scholar